{"pmid":32356760,"title":"The role of imaging in the detection and management of COVID-19: a review.","text":["The role of imaging in the detection and management of COVID-19: a review.","Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading rapidly around the world, resulting in a massive death toll. Lung infection or pneumonia is the common complication of COVID-19, and imaging techniques, especially computed tomography (CT), have played an important role in diagnosis and treatment assessment of the disease. Herein, we review the imaging characteristics and computing models that have been applied for the management of COVID-19. CT, positron emission tomography - CT (PET/CT), lung ultrasound, and magnetic resonance imaging (MRI) have been used for detection, treatment, and follow-up. The quantitative analysis of imaging data using artificial intelligence (AI) is also explored. Our findings indicate that typical imaging characteristics and their changes can play crucial roles in the detection and management of COVID-19. In addition, AI or other quantitative image analysis methods are urgently needed to maximize the value of imaging in the management of COVID-19.","IEEE Rev Biomed Eng","Dong, Di","Tang, Zhenchao","Wang, Shuo","Hui, Hui","Gong, Lixin","Lu, Yao","Xue, Zhong","Liao, Hongen","Chen, Fang","Yang, Fan","Jin, Ronghua","Wang, Kun","Liu, Zhenyu","Wei, Jingwei","Mu, Wei","Zhang, Hui","Jiang, Jingying","Tian, Jie","Li, Hongjun","32356760"],"abstract":["Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading rapidly around the world, resulting in a massive death toll. Lung infection or pneumonia is the common complication of COVID-19, and imaging techniques, especially computed tomography (CT), have played an important role in diagnosis and treatment assessment of the disease. Herein, we review the imaging characteristics and computing models that have been applied for the management of COVID-19. CT, positron emission tomography - CT (PET/CT), lung ultrasound, and magnetic resonance imaging (MRI) have been used for detection, treatment, and follow-up. The quantitative analysis of imaging data using artificial intelligence (AI) is also explored. Our findings indicate that typical imaging characteristics and their changes can play crucial roles in the detection and management of COVID-19. In addition, AI or other quantitative image analysis methods are urgently needed to maximize the value of imaging in the management of COVID-19."],"journal":"IEEE Rev Biomed Eng","authors":["Dong, Di","Tang, Zhenchao","Wang, Shuo","Hui, Hui","Gong, Lixin","Lu, Yao","Xue, Zhong","Liao, Hongen","Chen, Fang","Yang, Fan","Jin, Ronghua","Wang, Kun","Liu, Zhenyu","Wei, Jingwei","Mu, Wei","Zhang, Hui","Jiang, Jingying","Tian, Jie","Li, Hongjun"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32356760","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1109/RBME.2020.2990959","topics":["Diagnosis"],"weight":1,"_version_":1666138495169593345,"score":9.490897,"similar":[{"pmid":32305937,"title":"Review of Artificial Intelligence Techniques in Imaging Data Acquisition, Segmentation and Diagnosis for COVID-19.","text":["Review of Artificial Intelligence Techniques in Imaging Data Acquisition, Segmentation and Diagnosis for COVID-19.","The pandemic of coronavirus disease 2019 (COVID-19) is spreading all over the world. Medical imaging such as X-ray and computed tomography (CT) plays an essential role in the global fight against COVID-19, whereas the recently emerging artificial intelligence (AI) technologies further strengthen the power of the imaging tools and help medical specialists. We hereby review the rapid responses in the community of medical imaging (empowered by AI) toward COVID-19. For example, AI-empowered image acquisition can significantly help automate the scanning procedure and also reshape the workflow with minimal contact to patients, providing the best protection to the imaging technicians. Also, AI can improve work efficiency by accurate delineation of infections in X-ray and CT images, facilitating subsequent quantification. Moreover, the computer-aided platforms help radiologists make clinical decisions, i.e., for disease diagnosis, tracking, and prognosis. In this review paper, we thus cover the entire pipeline of medical imaging and analysis techniques involved with COVID-19, including image acquisition, segmentation, diagnosis, and follow-up. We particularly focus on the integration of AI with X-ray and CT, both of which are widely used in the frontline hospitals, in order to depict the latest progress of medical imaging and radiology fighting against COVID-19.","IEEE Rev Biomed Eng","Shi, Feng","Wang, Jun","Shi, Jun","Wu, Ziyan","Wang, Qian","Tang, Zhenyu","He, Kelei","Shi, Yinghuan","Shen, Dinggang","32305937"],"abstract":["The pandemic of coronavirus disease 2019 (COVID-19) is spreading all over the world. Medical imaging such as X-ray and computed tomography (CT) plays an essential role in the global fight against COVID-19, whereas the recently emerging artificial intelligence (AI) technologies further strengthen the power of the imaging tools and help medical specialists. We hereby review the rapid responses in the community of medical imaging (empowered by AI) toward COVID-19. For example, AI-empowered image acquisition can significantly help automate the scanning procedure and also reshape the workflow with minimal contact to patients, providing the best protection to the imaging technicians. Also, AI can improve work efficiency by accurate delineation of infections in X-ray and CT images, facilitating subsequent quantification. Moreover, the computer-aided platforms help radiologists make clinical decisions, i.e., for disease diagnosis, tracking, and prognosis. In this review paper, we thus cover the entire pipeline of medical imaging and analysis techniques involved with COVID-19, including image acquisition, segmentation, diagnosis, and follow-up. We particularly focus on the integration of AI with X-ray and CT, both of which are widely used in the frontline hospitals, in order to depict the latest progress of medical imaging and radiology fighting against COVID-19."],"journal":"IEEE Rev Biomed Eng","authors":["Shi, Feng","Wang, Jun","Shi, Jun","Wu, Ziyan","Wang, Qian","Tang, Zhenyu","He, Kelei","Shi, Yinghuan","Shen, Dinggang"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305937","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1109/RBME.2020.2987975","topics":["Diagnosis"],"weight":1,"_version_":1666138493378625536,"score":299.9224},{"pmid":32436845,"title":"A review on the use of artificial intelligence for medical imaging of the lungs of patients with coronavirus disease 2019.","text":["A review on the use of artificial intelligence for medical imaging of the lungs of patients with coronavirus disease 2019.","The results of research on the use of artificial intelligence (AI) for medical imaging of the lungs of patients with coronavirus disease 2019 (COVID-19) has been published in various forms. In this study, we reviewed the AI for diagnostic imaging of COVID-19 pneumonia. PubMed, arXiv, medRxiv, and Google scholar were used to search for AI studies. There were 15 studies of COVID-19 that used AI for medical imaging. Of these, 11 studies used AI for computed tomography (CT) and 4 used AI for chest radiography. Eight studies presented independent test data, 5 used disclosed data, and 4 disclosed the AI source codes. The number of datasets ranged from 106 to 5941, with sensitivities ranging from 0.67-1.00 and specificities ranging from 0.81-1.00 for prediction of COVID-19 pneumonia. Four studies with independent test datasets showed a breakdown of the data ratio and reported prediction of COVID-19 pneumonia with sensitivity, specificity, and area under the curve (AUC). These 4 studies showed very high sensitivity, specificity, and AUC, in the range of 0.9-0.98, 0.91-0.96, and 0.96-0.99, respectively.","Diagn Interv Radiol","Ito, Rintaro","Iwano, Shingo","Naganawa, Shinji","32436845"],"abstract":["The results of research on the use of artificial intelligence (AI) for medical imaging of the lungs of patients with coronavirus disease 2019 (COVID-19) has been published in various forms. In this study, we reviewed the AI for diagnostic imaging of COVID-19 pneumonia. PubMed, arXiv, medRxiv, and Google scholar were used to search for AI studies. There were 15 studies of COVID-19 that used AI for medical imaging. Of these, 11 studies used AI for computed tomography (CT) and 4 used AI for chest radiography. Eight studies presented independent test data, 5 used disclosed data, and 4 disclosed the AI source codes. The number of datasets ranged from 106 to 5941, with sensitivities ranging from 0.67-1.00 and specificities ranging from 0.81-1.00 for prediction of COVID-19 pneumonia. Four studies with independent test datasets showed a breakdown of the data ratio and reported prediction of COVID-19 pneumonia with sensitivity, specificity, and area under the curve (AUC). These 4 studies showed very high sensitivity, specificity, and AUC, in the range of 0.9-0.98, 0.91-0.96, and 0.96-0.99, respectively."],"journal":"Diagn Interv Radiol","authors":["Ito, Rintaro","Iwano, Shingo","Naganawa, Shinji"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32436845","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.5152/dir.2019.20294","topics":["Diagnosis"],"weight":1,"_version_":1667521393736024064,"score":249.89038},{"pmid":32367319,"pmcid":"PMC7197034","title":"Artificial intelligence to codify lung CT in Covid-19 patients.","text":["Artificial intelligence to codify lung CT in Covid-19 patients.","The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already assumed pandemic proportions, affecting over 100 countries in few weeks. A global response is needed to prepare health systems worldwide. Covid-19 can be diagnosed both on chest X-ray and on computed tomography (CT). Asymptomatic patients may also have lung lesions on imaging. CT investigation in patients with suspicion Covid-19 pneumonia involves the use of the high-resolution technique (HRCT). Artificial intelligence (AI) software has been employed to facilitate CT diagnosis. AI software must be useful categorizing the disease into different severities, integrating the structured report, prepared according to subjective considerations, with quantitative, objective assessments of the extent of the lesions. In this communication, we present an example of a good tool for the radiologist (Thoracic VCAR software, GE Healthcare, Italy) in Covid-19 diagnosis (Pan et al. in Radiology, 2020. https://doi.org/10.1148/radiol.2020200370). Thoracic VCAR offers quantitative measurements of the lung involvement. Thoracic VCAR can generate a clear, fast and concise report that communicates vital medical information to referring physicians. In the post-processing phase, software, thanks to the help of a colorimetric map, recognizes the ground glass and differentiates it from consolidation and quantifies them as a percentage with respect to the healthy parenchyma. AI software therefore allows to accurately calculate the volume of each of these areas. Therefore, keeping in mind that CT has high diagnostic sensitivity in identifying lesions, but not specific for Covid-19 and similar to other infectious viral diseases, it is mandatory to have an AI software that expresses objective evaluations of the percentage of ventilated lung parenchyma compared to the affected one.","Radiol Med","Belfiore, Maria Paola","Urraro, Fabrizio","Grassi, Roberta","Giacobbe, Giuliana","Patelli, Gianluigi","Cappabianca, Salvatore","Reginelli, Alfonso","32367319"],"abstract":["The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already assumed pandemic proportions, affecting over 100 countries in few weeks. A global response is needed to prepare health systems worldwide. Covid-19 can be diagnosed both on chest X-ray and on computed tomography (CT). Asymptomatic patients may also have lung lesions on imaging. CT investigation in patients with suspicion Covid-19 pneumonia involves the use of the high-resolution technique (HRCT). Artificial intelligence (AI) software has been employed to facilitate CT diagnosis. AI software must be useful categorizing the disease into different severities, integrating the structured report, prepared according to subjective considerations, with quantitative, objective assessments of the extent of the lesions. In this communication, we present an example of a good tool for the radiologist (Thoracic VCAR software, GE Healthcare, Italy) in Covid-19 diagnosis (Pan et al. in Radiology, 2020. https://doi.org/10.1148/radiol.2020200370). Thoracic VCAR offers quantitative measurements of the lung involvement. Thoracic VCAR can generate a clear, fast and concise report that communicates vital medical information to referring physicians. In the post-processing phase, software, thanks to the help of a colorimetric map, recognizes the ground glass and differentiates it from consolidation and quantifies them as a percentage with respect to the healthy parenchyma. AI software therefore allows to accurately calculate the volume of each of these areas. Therefore, keeping in mind that CT has high diagnostic sensitivity in identifying lesions, but not specific for Covid-19 and similar to other infectious viral diseases, it is mandatory to have an AI software that expresses objective evaluations of the percentage of ventilated lung parenchyma compared to the affected one."],"journal":"Radiol Med","authors":["Belfiore, Maria Paola","Urraro, Fabrizio","Grassi, Roberta","Giacobbe, Giuliana","Patelli, Gianluigi","Cappabianca, Salvatore","Reginelli, Alfonso"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32367319","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1007/s11547-020-01195-x","keywords":["artificial intelligence","sars-cov-2","structured report"],"locations":["Thoracic","Italy","Radiology","Thoracic","Thoracic"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1666138496176226304,"score":246.80136},{"pmid":32503829,"title":"COVID-19 Incidentally Detected on PET/CT During Work-up for Locally Advanced Head and Neck Cancer.","text":["COVID-19 Incidentally Detected on PET/CT During Work-up for Locally Advanced Head and Neck Cancer.","AIM: To describe the incidental detection of COVID-19 disease on positron-emission tomography/computed tomography (PET/CT) in a patient with cancer despite initial negative swab by polymerase chain reaction (PCR). CASE REPORT: Clinical and radiographic data were obtained from the electronic medical record. Nasopharyngeal swabs were obtained and evaluated for COVID-19 by the Food and Drug Administration-approved reverse transcription-PCR assays. On radiographic examination, PET/CT was consistent with COVID-19-related pneumonia not seen on prior imaging. Initial nasopharyngeal swab 2 days after PET/CT imaging was negative for COVID-19. Subsequent repeat swab 10 days later was positive for COVID-19, while the patient was febrile on screening assessment. The patient remained COVID-19-positive until 1 month after abnormal PET/CT imaging. CONCLUSION: PET/CT can be sensitive for early COVID-19 detection, even in the setting of a negative confirmatory PCR test. This highlights the importance of continued patient surveillance and use of appropriate personal protective equipment to minimize COVID-19 transmission.","In Vivo","Mo, Allen","Brodin, N Patrik","Tome, Wolfgang A","Garg, Madhur K","Kabarriti, Rafi","32503829"],"abstract":["AIM: To describe the incidental detection of COVID-19 disease on positron-emission tomography/computed tomography (PET/CT) in a patient with cancer despite initial negative swab by polymerase chain reaction (PCR). CASE REPORT: Clinical and radiographic data were obtained from the electronic medical record. Nasopharyngeal swabs were obtained and evaluated for COVID-19 by the Food and Drug Administration-approved reverse transcription-PCR assays. On radiographic examination, PET/CT was consistent with COVID-19-related pneumonia not seen on prior imaging. Initial nasopharyngeal swab 2 days after PET/CT imaging was negative for COVID-19. Subsequent repeat swab 10 days later was positive for COVID-19, while the patient was febrile on screening assessment. The patient remained COVID-19-positive until 1 month after abnormal PET/CT imaging. CONCLUSION: PET/CT can be sensitive for early COVID-19 detection, even in the setting of a negative confirmatory PCR test. This highlights the importance of continued patient surveillance and use of appropriate personal protective equipment to minimize COVID-19 transmission."],"journal":"In Vivo","authors":["Mo, Allen","Brodin, N Patrik","Tome, Wolfgang A","Garg, Madhur K","Kabarriti, Rafi"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32503829","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.21873/invivo.11961","keywords":["covid-19","pet/ct","cancer","incidental detection","radiation therapy"],"topics":["Diagnosis"],"weight":1,"_version_":1668892488284241921,"score":242.37428},{"pmid":32451194,"pmcid":"PMC7200381","title":"Lung Ultrasound in Patients with Acute Respiratory Failure Reduces Conventional Imaging and Health Care Provider Exposure to COVID-19.","text":["Lung Ultrasound in Patients with Acute Respiratory Failure Reduces Conventional Imaging and Health Care Provider Exposure to COVID-19.","Lung ultrasound gained a leading position in the last year as an imaging technique for the assessment and management of patients with acute respiratory failure. In coronavirus disease 2019 (COVID-19), its role may be of further importance because it is performed bedside and may limit chest X-ray and the need for transport to radiology for computed tomography (CT) scan. Since February 21, we progressively turned into a coronavirus-dedicated intensive care unit and applied an ultrasound-based approach to avoid traditional imaging and limit contamination as much as possible. We performed a complete daily examination with lung ultrasound score computation and systematic search of complications (pneumothorax, ventilator-associated pneumonia); on-duty physicians were free to perform CT or chest X-ray when deemed indicated. We compared conventional imaging exams performed in the first 4 wk of the COVID-19 epidemic with those in the same time frame in 2019: there were 84 patients in 2020 and 112 in 2019; 64 and 22 (76.2% vs. 19.6%, p < 0.001) had acute respiratory failure, respectively, of which 55 (85.9%) were COVID-19 in 2020. When COVID-19 patients in 2020 were compared with acute respiratory failure patients in 2019, the median number of chest X-rays was 1.0 (1.0-2.0) versus 3.0 (1.0-4.0) (p=0.0098); 2 patients 2 (3.6%) versus 7 patients (31.8%) had undergone at least one thoracic CT scan (p=0.001). A self-imposed ultrasound-based approach reduces the number of chest X-rays and thoracic CT scans in COVID-19 patients compared with patients with standard acute respiratory failure, thus reducing the number of health care providers exposed to possible contamination and sparing personal protective equipment.","Ultrasound Med Biol","Mongodi, Silvia","Orlando, Anita","Arisi, Eric","Tavazzi, Guido","Santangelo, Erminio","Caneva, Luca","Pozzi, Marco","Pariani, Eleonora","Bettini, Giada","Maggio, Giuseppe","Perlini, Stefano","Preda, Lorenzo","Iotti, Giorgio Antonio","Mojoli, Francesco","32451194"],"abstract":["Lung ultrasound gained a leading position in the last year as an imaging technique for the assessment and management of patients with acute respiratory failure. In coronavirus disease 2019 (COVID-19), its role may be of further importance because it is performed bedside and may limit chest X-ray and the need for transport to radiology for computed tomography (CT) scan. Since February 21, we progressively turned into a coronavirus-dedicated intensive care unit and applied an ultrasound-based approach to avoid traditional imaging and limit contamination as much as possible. We performed a complete daily examination with lung ultrasound score computation and systematic search of complications (pneumothorax, ventilator-associated pneumonia); on-duty physicians were free to perform CT or chest X-ray when deemed indicated. We compared conventional imaging exams performed in the first 4 wk of the COVID-19 epidemic with those in the same time frame in 2019: there were 84 patients in 2020 and 112 in 2019; 64 and 22 (76.2% vs. 19.6%, p < 0.001) had acute respiratory failure, respectively, of which 55 (85.9%) were COVID-19 in 2020. When COVID-19 patients in 2020 were compared with acute respiratory failure patients in 2019, the median number of chest X-rays was 1.0 (1.0-2.0) versus 3.0 (1.0-4.0) (p=0.0098); 2 patients 2 (3.6%) versus 7 patients (31.8%) had undergone at least one thoracic CT scan (p=0.001). A self-imposed ultrasound-based approach reduces the number of chest X-rays and thoracic CT scans in COVID-19 patients compared with patients with standard acute respiratory failure, thus reducing the number of health care providers exposed to possible contamination and sparing personal protective equipment."],"journal":"Ultrasound Med Biol","authors":["Mongodi, Silvia","Orlando, Anita","Arisi, Eric","Tavazzi, Guido","Santangelo, Erminio","Caneva, Luca","Pozzi, Marco","Pariani, Eleonora","Bettini, Giada","Maggio, Giuseppe","Perlini, Stefano","Preda, Lorenzo","Iotti, Giorgio Antonio","Mojoli, Francesco"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451194","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.ultrasmedbio.2020.04.033","keywords":["ards","covid-19","lung monitoring","lung ultrasound","severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"],"locations":["thoracic"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1667983494578438144,"score":215.01602}]}